HIV-1 genetic diversity and genotypic drug susceptibility in the Republic of Georgia

AIDS Research and Human Retroviruses

Volumn 22, Issue 5, 2006, Pages 470-476

  Zarandia, Maia ^a   Tsertsvadze, Tengiz ^a   Carr, Jean K ^b,e   Nadai, Yuka ^c   Sanchez, Jose L ^c   Nelson, Kenrad ^d  

^a AIDS and Clinical Immunology Research Center   (Georgia)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GENOMIC DNA;

ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; DRUG SENSITIVITY; EPIDEMIC; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; GEORGIA (REPUBLIC); HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN IDENTIFICATION; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS MUTATION; VIRUS TRANSMISSION;

ADULT; BASE SEQUENCE; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; GENOME, VIRAL; GEORGIA (REPUBLIC); HETEROSEXUALITY; HETEROZYGOTE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA; SUBSTANCE ABUSE, INTRAVENOUS; USSR; VARIATION (GENETICS);

EID: 33646888185     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.470     Document Type: Article

References (22)

1. Kobyshka Y, Shcerbinskaia A, Khodakevich L, et al.: HIV infection among drug users in Ukraine: Beginning of the epidemic. In: XIth International AIDS Conference, Vancouver, BC, Canada, 1996 (abstract Tu C204).
2. Bobkov A, Chenginsov-Popov R, Selimova L, et al.: An HIV-1 epidemic among injecting drug users in the former Soviet Union caused by a homogenous subtype A strain. AIDS Res Human Retroviruses 1997;314:1783.
3. UNAIDS/UNICEF/WHO: Report on the Global HIV/AIDS Epidemic, July 2002. www.who.int/hiv/pub/epidemiology/pubepidemic2002/en/
4. Bobkov A, Kazennova E, Selimova L, et al.: A sudden epidemic of HIV type 1 among injecting drug users in the former soviet Union: Identification of subtype A, subtype B, and novel gagA/envB recombinants. AIDS Res Hum Retroviruses 1998;14:669-676.
5. Liitsola K, Tashkinova I, Laukkanen T, et al.: HV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-1909.
6. Reinis M, Bruckova M, Graham RR, et al.: Genetic subtypes of HIV type 1 viruses circulating in the Czech Republic. AIDS Res Human Retroviruses 2001;17:1305-1310.
7. Devereux H, Loveday C, Burke A, et al.: The prevalence of non-B subype HIV-1 in a London HIV/AIDS outpatient clinic. AIDS 1999;13:142.
8. Carr JK, Nadai Y, Eyzaguiire L, et al.: Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan. J AIDS 2005;39:570-575.
9. Tkeshelashvili-Kessler A, del Rio C, Nelson KE, et al.: The emerging HIV/AIDS epidemic in Georgia. Int J STD AIDS 2005;16:61-67.
10. Gvetadze R, Shartava T, Badridze N, et al.: Prevalence and incidence of HIV in selected populations in the Republic of Georgia. Clin Infect Dis 1999;29:1027.
11. UNAIDS/WHO: Epidemiological Fact Sheet on HIV/AIDS: Republic of Georgia, 2002 Update. 2002. www.who.int/hiv/countries/en/
12. Ammaranond, P, Cunningham P, Oelrichs R, et al.: Rates of transmission of antiretroviral drug resistant strains of HIV-1. J Clin Virol 2003;26:153-161.
13. Parikh U, Calef C, Larder B, et al.: Mutations in retroviral genes associated with drug resistance. In: HIV Sequence Compendium 2002. (Kuiken CL, Foley B , Freed E, et al., eds.). Los Alamos National Laboratory, Los Alamos, New Mexico, pp. 94-183.
14. Borman AM, Paulus S, and Clavel F: Resistance of human immunodeficiency virus type 1 to protease inhibitors: Selection of resistance mutations in the presence and absence of the drug. J Gen Virol 1990;66:419-436.
15. Patic AK, Duran M, Cao Y, et al.: Genotypic and phenotypic characterization of human immunodeficiency virus type 1 variants isolated from patients treated with the protease inhibitor nelfinavir. Antimicrob Agents Chemother 1998;42:2637-2644.
16. Roudinskii NI, Sukhanova AL, Kazennova EV, et al.: Diversity of human imunodeficiency virus type 1 subtype A and CRFO3_AB protease in Eastern Europe: Selection of the V77I variant and its rapid spread in injecting drug user populations. J Virol 2004;78:11276-11287.
17. Salminen MO, Koch C, Sanders-Buell E, et al.: Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 1995;213:80-86.
18. Carr JK, Laukkanen T, Salminen MO, et al.: Characterization of subype A HIV-1 from Africa by full genome sequencing. AIDS 1999;13:1819-1826.
19. Felsenstein J: PHILIP (Phylogeny Interference Package), 3.52c. Department of Genetics, University of Washington, Seattle, Washington, 1992.
20. Lole KS, Bollinger RC, Paranjape RS, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160.
21. Shafer RW, Jung DR, Betts BJ, et al.: Human immunodeficiency virus reverse transcriptase and protease sequence database. Nucleic Acids Res 2000;28:346-348.
22. Thomson MM, Casado G, Posada D, et al.: Identification of novel HIV-1 complex circulating recombinant form (CRF18_cpx) of Central African origin in Cuba. AIDS 2005;19:1155-1163.